From cancer neutralization to fertility preservation
Scientists are working to provide fertility options for cancer patients and expand the menu of cancer therapies.
Immunology
Piet Borst receives the Lasker~Koshland Special Achievement Award
The Lasker Foundation honored Piet Borst for his outstanding research, leadership, and mentorship across various fields, including cancer drug resistance.
Science Milestone: The rise of Herceptin
Herceptin transformed breast cancer treatment and opened the door to targeted therapy.
2024 Breakthrough Prizes in Life Sciences
This year’s Breakthrough Prizes honor advances in CAR T cancer therapies, cystic fibrosis, and Parkinson’s disease.
Rewiring cell communication to treat melanoma
Exosomes show encouraging results for treating melanoma, offering potential benefits for targeted drug delivery and immunotherapy
Advancing immune forces at the tumor frontlines
Epigenetic therapies revive the immune cell offensive in immunotherapy resistant tumors.
Biomaterials for better diabetes cell therapy
Aiming to restore insulin function in type 1 diabetes, Lonnie Shea develops scaffolds that support the growth and transplantation of pancreatic islet structures.
An mRNA twist to the HIV vaccine problem
For decades, researchers have tried to craft a successful vaccine for HIV. mRNA vaccines may offer the answer.
Modifying macrophages to attack solid tumors
A team of industry and academic researchers developed a new way to engineer the immune
system, leading to the first clinical trial using genetically modified macrophages.
Unraveling the molecular mechanisms of endometriosis
Bioengineer Linda Griffith creates tissue models to figure out what causes endometriosis and how to treat it.
